Compare SERA & OPNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SERA | OPNW |
|---|---|---|
| Founded | 2008 | 2023 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Precision Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 74.3M |
| IPO Year | 2021 | 2013 |
| Metric | SERA | OPNW |
|---|---|---|
| Price | $1.96 | $0.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | 16.2K | ★ 82.5K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $81,000.00 | ★ $16,398,000.00 |
| Revenue This Year | $177.78 | N/A |
| Revenue Next Year | $755.56 | $15.79 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 5.19 | N/A |
| 52 Week Low | $1.56 | $0.91 |
| 52 Week High | $3.85 | $6.69 |
| Indicator | SERA | OPNW |
|---|---|---|
| Relative Strength Index (RSI) | 43.21 | 13.24 |
| Support Level | $1.91 | N/A |
| Resistance Level | $2.03 | $6.69 |
| Average True Range (ATR) | 0.05 | 0.32 |
| MACD | -0.00 | -0.12 |
| Stochastic Oscillator | 15.38 | 0.33 |
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.